TAG-VE statement on the meeting of 3 January on the COVID-19 situation in China

WHO
Jan 04, 2023

TAG-VE statement on the meeting of 3 January on the COVID-19 situation in China


The Technical Advisory Group on Virus Evolution (TAG-VE) meets regularly to review the latest scientific evidence on circulating SARS-CoV-2 variants and advises WHO on whether a change in public health strategies is warranted. The TAG-VE met on 3 January 2023 to discuss the COVID-19 situation in mainland China.

During the meeting, scientists from the China CDC presented genomic data from what they described as imported as well as locally-acquired cases of SARS-CoV-2 infections. For locally-acquired infections, data presented were based on more than 2000 genomes collected and sequenced from 1 December 2022. The China CDC analysis showed a predominance of Omicron lineages BA.5.2 and BF.7 among locally-acquired infections. BA.5.2 and BF.7 together accounted for 97.5% of all local infections as per genomic sequencing. A few other known Omicron sublineages were also detected albeit in low percentages. These variants are known and have been circulating in other countries, and at the present time no new variant has been reported by the China CDC.